AllianceBernstein’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-111,520
| Closed | -$515K | – | 3237 |
|
|
2019
Q1 | $515K | Buy |
111,520
+5,800
| +5% | +$27.5K | ﹤0.01% | 2509 |
|
|
2018
Q4 | $370K | Hold |
105,720
| – | – | ﹤0.01% | 2615 |
|
|
2018
Q3 | $1.07M | Hold |
105,720
| – | – | ﹤0.01% | 2301 |
|
|
2018
Q2 | $765K | Buy |
105,720
+19,200
| +22% | +$134K | ﹤0.01% | 2434 |
|
|
2018
Q1 | $523K | Buy |
86,520
+11,900
| +16% | +$98.3K | ﹤0.01% | 2511 |
|
|
2017
Q4 | $718K | Buy |
74,620
+6,600
| +10% | +$43.2K | ﹤0.01% | 2436 |
|
|
2017
Q3 | $604K | Sell |
68,020
-72,820
| -52% | -$751K | ﹤0.01% | 2506 |
|
|
2017
Q2 | $1.78M | Buy |
140,840
+79,220
| +129% | +$937K | ﹤0.01% | 1941 |
|
|
2017
Q1 | $648K | Buy |
61,620
+9,400
| +18% | +$100K | ﹤0.01% | 2442 |
|
|
2016
Q4 | $480K | Sell |
52,220
-105,330
| -67% | -$1.19M | ﹤0.01% | 2576 |
|
|
2016
Q3 | $1.86M | Buy |
157,550
+96,430
| +158% | +$1.47M | ﹤0.01% | 1835 |
|
|
2016
Q2 | $791K | Buy |
61,120
+2,150
| +4% | +$31.3K | ﹤0.01% | 2333 |
|
|
2016
Q1 | $943K | Buy |
58,970
+11,150
| +23% | +$212K | ﹤0.01% | 2133 |
|
|
2015
Q4 | $1.37M | Hold |
47,820
| – | – | ﹤0.01% | 1918 |
|
|
2015
Q3 | $1.36M | Sell |
47,820
-9,480
| -17% | -$349K | ﹤0.01% | 1961 |
|
|
2015
Q2 | $2.06M | Buy |
57,300
+9,900
| +21% | +$308K | ﹤0.01% | 1773 |
|
|
2015
Q1 | $1.38M | Sell |
47,400
-1,600
| -3% | -$42.3K | ﹤0.01% | 2002 |
|
|
2014
Q4 | $1.03M | Sell |
49,000
-11,200
| -19% | -$221K | ﹤0.01% | 2191 |
|
|
2014
Q3 | $1.17M | Sell |
60,200
-11,600
| -16% | -$182K | ﹤0.01% | 2100 |
|
|
2014
Q2 | $1.12M | Sell |
71,800
-1,300,564
| -95% | -$21M | ﹤0.01% | 2177 |
|
|
2014
Q1 | $28.4M | Buy |
1,372,364
+1,353,950
| +7,353% | +$26.9M | 0.02% | 604 |
|
|
2013
Q4 | $238K | Buy |
18,414
+16,200
| +732% | +$225K | ﹤0.01% | 2745 |
|
|
2013
Q3 | $26K | Sell |
2,214
-1,572
| -42% | -$12.9K | ﹤0.01% | 3087 |
|
|
2013
Q2 | $17K | Buy |
+3,786
| New | +$13.9K | ﹤0.01% | 3084 |
|
Other funds holding INSY
WS
AllianceBernstein's INSY Position: Q2 2019 in Review
AllianceBernstein sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 111,520 shares — an estimated $515K sold.
AllianceBernstein first reported a position in INSY in Q2 2013 and held it in 24 quarters. The position peaked at $28.4M in Q1 2014. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.
- AllianceBernstein reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
- AllianceBernstein sold 111,520 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $515K.
- AllianceBernstein first reported a position in Insys Therapeutics, Inc. in Q2 2013 and held it in 24 quarters.
- AllianceBernstein's Insys Therapeutics, Inc. position peaked at $28.4M in Q1 2014.
- 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.
Based on AllianceBernstein's 13F filing for Q2 2019, filed 14 Aug 2019.